
Phuong N. Huynh
Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 2195 |
| Issued Applications | 1131 |
| Pending Applications | 251 |
| Abandoned Applications | 828 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5603161
[patent_doc_number] => 20060293506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Antibodies directed to PDGFD and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/109181
[patent_app_country] => US
[patent_app_date] => 2005-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 26087
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293506.pdf
[firstpage_image] =>[orig_patent_app_number] => 11109181
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/109181 | Antibodies directed to PDGFD and uses thereof | Apr 17, 2005 | Abandoned |
Array
(
[id] => 4652146
[patent_doc_number] => 20080039402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Peptides and Peptidomimetics Binding to Cd23'
[patent_app_type] => utility
[patent_app_number] => 10/594674
[patent_app_country] => US
[patent_app_date] => 2005-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11605
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039402.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594674
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594674 | Peptides and peptidomimetics binding to CD23 | Apr 4, 2005 | Issued |
Array
(
[id] => 7193056
[patent_doc_number] => 20050163779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor'
[patent_app_type] => utility
[patent_app_number] => 11/097334
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163779.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097334
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097334 | Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor | Apr 3, 2005 | Issued |
Array
(
[id] => 543064
[patent_doc_number] => 07163802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-16
[patent_title] => 'Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use'
[patent_app_type] => utility
[patent_app_number] => 11/090353
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 11953
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/163/07163802.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090353 | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use | Mar 24, 2005 | Issued |
Array
(
[id] => 6951767
[patent_doc_number] => 20050226861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Immunogen adherence inhibitor and method of making and using same'
[patent_app_type] => utility
[patent_app_number] => 11/085674
[patent_app_country] => US
[patent_app_date] => 2005-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9052
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20050226861.pdf
[firstpage_image] =>[orig_patent_app_number] => 11085674
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/085674 | Immunogen adherence inhibitor and method of making and using same | Mar 20, 2005 | Abandoned |
Array
(
[id] => 5819989
[patent_doc_number] => 20060024302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 11/074373
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 26558
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024302.pdf
[firstpage_image] =>[orig_patent_app_number] => 11074373
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/074373 | Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same | Mar 6, 2005 | Abandoned |
Array
(
[id] => 5159446
[patent_doc_number] => 20070172490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Leukocyte stimulation matrix'
[patent_app_type] => utility
[patent_app_number] => 10/591470
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5785
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172490.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591470
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591470 | Leukocyte stimulation matrix | Mar 3, 2005 | Abandoned |
Array
(
[id] => 6957910
[patent_doc_number] => 20050214280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Method for inhibiting tumor formation and growth'
[patent_app_type] => utility
[patent_app_number] => 11/068888
[patent_app_country] => US
[patent_app_date] => 2005-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10555
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214280.pdf
[firstpage_image] =>[orig_patent_app_number] => 11068888
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/068888 | Method for inhibiting tumor formation and growth | Mar 1, 2005 | Abandoned |
Array
(
[id] => 5296019
[patent_doc_number] => 20090010945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Partially Loaded Antibodies And Methods Of Their Conjugation'
[patent_app_type] => utility
[patent_app_number] => 10/591743
[patent_app_country] => US
[patent_app_date] => 2005-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28481
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20090010945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591743
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591743 | Partially loaded antibodies and methods of their conjugation | Mar 1, 2005 | Issued |
Array
(
[id] => 267022
[patent_doc_number] => 07566546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-28
[patent_title] => 'Modulators of angiogenesis and tumorigenesis'
[patent_app_type] => utility
[patent_app_number] => 11/060659
[patent_app_country] => US
[patent_app_date] => 2005-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 20264
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/566/07566546.pdf
[firstpage_image] =>[orig_patent_app_number] => 11060659
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/060659 | Modulators of angiogenesis and tumorigenesis | Feb 15, 2005 | Issued |
Array
(
[id] => 5793564
[patent_doc_number] => 20060014245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Fusion proteins containing recombinant cytotoxic RNAses'
[patent_app_type] => utility
[patent_app_number] => 11/056182
[patent_app_country] => US
[patent_app_date] => 2005-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12109
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014245.pdf
[firstpage_image] =>[orig_patent_app_number] => 11056182
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/056182 | Fusion proteins containing recombinant cytotoxic RNAses | Feb 13, 2005 | Issued |
Array
(
[id] => 651082
[patent_doc_number] => 07112659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-26
[patent_title] => 'OB fusion protein compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/054085
[patent_app_country] => US
[patent_app_date] => 2005-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13372
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112659.pdf
[firstpage_image] =>[orig_patent_app_number] => 11054085
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/054085 | OB fusion protein compositions and methods | Feb 7, 2005 | Issued |
Array
(
[id] => 6911861
[patent_doc_number] => 20050175619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Methods of producing antibody conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/050981
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10823
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175619.pdf
[firstpage_image] =>[orig_patent_app_number] => 11050981
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/050981 | Methods of producing antibody conjugates | Feb 3, 2005 | Abandoned |
Array
(
[id] => 8784512
[patent_doc_number] => 08431355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Process for screening glycoform-specific antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/588220
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 72
[patent_no_of_words] => 17672
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10588220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/588220 | Process for screening glycoform-specific antibodies | Feb 3, 2005 | Issued |
Array
(
[id] => 7184765
[patent_doc_number] => 20050191671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Isolated human transporter cofactor proteins, nucleic acid molecules encoding human transporter cofactor proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/043932
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19960
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191671.pdf
[firstpage_image] =>[orig_patent_app_number] => 11043932
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/043932 | Isolated human transporter cofactor proteins, nucleic acid molecules encoding human transporter cofactor proteins and uses thereof | Jan 27, 2005 | Abandoned |
Array
(
[id] => 6374303
[patent_doc_number] => 20100075891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'Novel polynucleotides encoding polypeptides and methods using same'
[patent_app_type] => utility
[patent_app_number] => 11/043770
[patent_app_country] => US
[patent_app_date] => 2005-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 299
[patent_figures_cnt] => 299
[patent_no_of_words] => 236427
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11043770
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/043770 | Polynucleotides encoding polypeptides and methods using same | Jan 26, 2005 | Issued |
Array
(
[id] => 4955380
[patent_doc_number] => 20080188404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Hybrid And Chimeric Polypeptides That Regulate Activation Of Complement'
[patent_app_type] => utility
[patent_app_number] => 10/597373
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 12296
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20080188404.pdf
[firstpage_image] =>[orig_patent_app_number] => 10597373
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/597373 | Hybrid and chimeric polypeptides that regulate activation of complement | Jan 20, 2005 | Issued |
Array
(
[id] => 4955380
[patent_doc_number] => 20080188404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Hybrid And Chimeric Polypeptides That Regulate Activation Of Complement'
[patent_app_type] => utility
[patent_app_number] => 10/597373
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 12296
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20080188404.pdf
[firstpage_image] =>[orig_patent_app_number] => 10597373
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/597373 | Hybrid and chimeric polypeptides that regulate activation of complement | Jan 20, 2005 | Issued |
Array
(
[id] => 7192980
[patent_doc_number] => 20050163770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Immunological reagent specifically interacting with the extracellular domain of the human zeta chain'
[patent_app_type] => utility
[patent_app_number] => 11/036098
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17962
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163770.pdf
[firstpage_image] =>[orig_patent_app_number] => 11036098
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/036098 | Immunological reagent specifically interacting with the extracellular domain of the human zeta chain | Jan 17, 2005 | Abandoned |
Array
(
[id] => 5545389
[patent_doc_number] => 20090155266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Methods and Compositions Relating to Vascular Endothelial Growth Factor and TH2 Mediated Inflammatory Diseases'
[patent_app_type] => utility
[patent_app_number] => 10/586254
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21421
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586254
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586254 | Methods and Compositions Relating to Vascular Endothelial Growth Factor and TH2 Mediated Inflammatory Diseases | Jan 17, 2005 | Abandoned |